Comment j'explore ... l'hypertension artérielle par excès de minéralocorticoides

[en] Primary aldosteronism is a rare cause of hypertension. However, its incidence seems to be underestimated. It is important to identify this syndrom since the disease is potentially curable. In the present paper, we depict different forms of primary aldosteronism as well as the diagnostic procedures. When the diagnosis is suspected (hypertension associated to spontaneous or diuretic-induced hypokaliemia), the more efficient screening test is the determination of the aldosteron/renin ratio. Saline infusion or posture tests can thereafter confirm the diagnosis. Differential diagnosis between bilateral and unilateral forms of primary aldosteronism can be made by CT-scanner and the response of aldosterone to the posture test. Such a complex assessment leads to the identification of patients who can be surgically treated. This treatment consists in a unilateral adrenalectomy which can be realised by laparoscopy.

Disciplines :

Human health sciences: Multidisciplinary, general & others

Author, co-author :

Bovy, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Delanaye, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Radermecker, Régis ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques

Hamoir, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation

Maweja, Sylvie ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie

Language :

French

Title :

Comment j'explore ... l'hypertension artérielle par excès de minéralocorticoides

Alternative titles :

[en] Hypertension Due to Primary Aldosteronism

Publication date :

April 2005

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

255-63

Peer reviewed :

Peer reviewed

Available on ORBi :

since 30 January 2009

Statistics

Number of views

215 (9 by ULiège)

Number of downloads

2909 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Arruza JL, Weinberger C, Cerelli G et al.- Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kindship with the glucocorticoid receptor. Science, 1987, 237, 268-275.
Edwards CRW, Stewart PM, But D et al.- Localisation of 11-beta-hyroxysteroid dehydrogenase-tissue protector of the mineralocorticoid receptor. Lancet, 1988, ii, 986-989.
Funder JW, Pearce PT, Smith R et al.- Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science, 1988, 242, 583-585.
Walker BR, Connacher AA, Webb DJ et al.- Glucocorticoids and blood pressure : a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci, 1992, 83, 171-178.
Ullian ME, Hazen-Martin DJ, Walsch LG et al.- Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings. Hypertension, 1996, 27, 1346-1352.
Gomez-Sanchez EP, Gomez-Sanchez CE.- Central hypertensinogenic effects of glycyrrhic acid and carbenoxolone. Am J Physiol, 1992, 263, E-1125-1130.
Weinberger MH, Fineberg NS.- The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med, 1993, 153, 2125-2129.
Tucker RM, Labarthe DR.- Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 to 1975. Mayo Clin Proc, 1977, 52, 549-555.
Lim PO, Jung RT, Mac Donald TM.- Raised-aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J Clin Pharmacol, 1999, 48, 756-760.
Lim PO, Mc Donald TM, Holloway C et al.- Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone to renin ratio. J Clin End Met, 2002, 87, 4398-4402.
Yong WF Jr, Hogan MJ, Klee CG et al.- Primary hyperaldosteronism: diagnosis and treatment. Mayo Clin Proc, 1990, 65, 96-110.
Ferrari P, Shaw SG, Nicod J et al.- Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J Hypertension, 2004, 22, 377-381.
Kem DC, Weinberger MH, Gomez-Sanchez CE et al.- Circadian rythms of plasma aldosterone concentration in normal subjects and patients with primary aldosteronism. J Clin Invest, 1973, 52, 2272-2277.
Hamlet SM, Tunny TJ, Woodland E et al.- Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin Exp Pharmacol Physiol, 1985, 12, 249-252.
Gordon, RD.- Primary aldosteronism. J Endocrinol Invest, 1995, 18, 495-511.
Gordon RD, Stowasser M, Tunny TJ et al.- High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Expt Pharmac Physiol, 1994, 21, 315-318.
Blumenfeld JD, Sealy JE, Schlussel Y et al.- Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med, 1994, 121, 877-885.
Hiramatsu K, Yamada T, Yukimura Y et al.- A screening test to identify aldosterone producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med, 1981, 141, 1589-1593.
Mc Kenna TJ, Sequeira SH, Hefferman A et al.- Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab, 1991, 73, 952-957.
Gordon, RD.- The challenge of more robust and reproductible methodology in screening for primary hyperaldosteronism. J Hypertension, 2004, 22, 251-255.
Gallay BJ, Ahmad S, Xu L et al.- Screening for primary aldosteronism without discontinuing hypertensive medications : plasma aldosterone-renin ratio. Am J Kidney Dis, 2001, 37, 699-705.
Castro OL, Yu Y, Kem DC.- Diagnostic value of the post-captopril test in primary aldosteronism. Hypertension, 2002, 39, 935-938.
Naomi S, Umeda T, Iwaoka T et al.- Effects of sodium intake on the captopril test for primary hyperaldosteronism. Jap Heart J, 1987, 28, 357-365.
Lyons DF, Kem DC, BRrown RD et al.- Single dose captopril as a diagnostic test for primary aldosteronism. Endocrinol Metab, 1991, 73, 952-957.
Hambling C, Jung RT, Gunn A et al.- Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin Endocrinol, 1992, 36, 499-503.
Muratini H, Abe I, Tomma Y et al.- Single oral administration of captopril may not bring an improvement in screening for primary hyperaldosteronism. Clin Exp Hypertens, 1987, A9, 611-614.
Arteaga E., Klein R., Biglieri EG.- Use of the saline infusion test to diagnose the cause of primary aldosteronism. Am J Med, 1985, 79, 722-727.
Wlisgenhof M, Brown RD, Hogan MJ et al.- The plasma aldosterone response to angiotensin II infusion in aldosterone-producting adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab, 1981, 52, 195-198.
Yamakita N, Mune T, Monta H et al.- Plasma 18-oxo-cortisol levels in the patients with adernocortical disorders. Clin Endocrinol, 1994, 40, 583-587.
Fontes RG, Kater JE, Biglieri EG et al.- Reassessement of the predictive value of the postural stimulation test in primary aldosteronism. Am J Hypertens, 1991, 4, 786-791.
Irony I, Kater CE, Biglieri EG et al.- Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens, 1990, 3, 576-582.
Mantero F, Armanini D, Biason A et al.- New aspects of mineralocorticoid hypertension. Horm Res, 1990, 34, 175-180.
Fraser R, Lantos CF.- 18-hydroxycorticosterone: a review. J Steroid Biochem, 1978, 9, 273-286.
Ulick S, Blumenfeld JD, Atlas SA et al.- The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J Clin Endocrinol Metab, 1993, 76, 873-878.
Copeland PM.- The incidentally discovered adrenal mass. Ann Intern Med, 1983, 98, 940-945.
Doppman JL, Miller DL.- Distribution between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology, 1992, 184, 677-682.
Dunnick NR, Leizn GS, Roubidoux M. et al.- CT in the diagnosis of primary aldosteronism: similarity in 29 patients. Am J Roentgenol, 1993, 160, 321-324.
Ikeda DM, Francis IR, Glazer PM et al.- The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy: CT and MR imaging. Am J Roentgenol, 1989, 153, 301-306.
Reznek RH, Armstrong P.- Imaging in endocrinology. The adrenal gland. Clin Endocrinol, 1994, 40, 561-576.
Osella G, Terzolo M., Borretta G et al.- Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab, 1994, 79, 1532-1539.
Young WF Jr, Klee GG.- Primary aldosteronism: diagnosis evaluation. Endocrinol Metab Clin North Am, 1988, 17, 367-395.
Gill JR Jr.- Primary hyperaldosteronism: strategies for diagnosis and treatment. Endocrinologist, 1991, 1, 365-369.
Tokinaga K, Nakamura H, Marukawa T et al.- Adrenal venous sampling analysis of primary aldosteronism: value of ACTH stimulation in the differentiation of adenoma and hyperplasia. Eur Radiol, 1992, 2, 223-229.
Ma JTC, Wang C, Lam KSL et al.- Fifty cases of primary hyperaldosteronism in Hong Kong Chinese with a high frequency of periodic paralysis: evaluation of techniques for tumour localization. Q J Med, 1986, 61, 1021-1037.
Doppman JL, Gill JR Jr.- Hyperaldosteronism: sampling the adrenal veins. Radiology, 1996, 198, 309-312.
Lifton RP, Dluhy RG, Powers M et al.- A chimaeric 11-β-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature, 1992, 335, 262-265.
Jonson JR, Klemm SA, Tunny TJ et al.- A new genetic test for familial hyperaldosteronism type 1 aids in the detection of curable hypertension. Biochem Biophys Res Communications, 1995, 2907, 565-571.
Banks WA, Kastin AJ, Ruiz AE et al.- Primary adrenal hyperplasia: a new subset of primary aldosteronism. Clin Endocrinol Metab, 1984, 58, 783-785.
Iron Y, Biglieri EG.- New types of primary aldosteronism. Clin Research, 1988, 36, 123A.
Shimkets RA, Warnock EG, Bositis CM et al.- Liddle's syndrome revisited - a disorder of sodium reabsorption in the distal tubule. New Engl J Med, 1994, 330, 178-181.
Hansson JH, Nelson-Williams C, Suzuki H et al.- Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet, 1995, 11, 76-82.
Melby JC.- Diagnosis of hyperaldosteronism. Endocrinol Metab Clin North Am, 1991, 20, 247-255.
Kelly WF, O'Hare MJ, Loizou S et al.- Hypermineralocorticism without excessive aldosterone secretion: an adrenal carcinoma producing deoxycorticosterone. Clin Endocrinol, 1982, 17, 353-361.